Alphapointe Receives Patent and Military Approval on Pneumatic Tourniquet, Getting Greenlight on Second Life-Saving Device in a Week

May 10, 2019, Kansas City, MO ~ For the second time in a week, Alphapointe has received notice that a life-saving device it developed has earned patent approval and received the green light for military use from the Department of Defense’s Committee for Tactical Combat Casually Care (CoTCCC). After learning on May 6 that it had secured final approval of its Tactical Medical Tourniquet (TMT), a field device developed in collaboration with the U.S. Army, Alphapointe was notified on May 8 that its Tactical Pneumatic Tourniquet (TPT) has secured similar approvals and will be listed as a “recommended limb tourniquet” for use by the military.

Read Full Press Release